Company Information

  

Address: PARC D'ACTIVITES LA POUDRETTE LAMARTINE
4 RUE DU DAUPHINE 
City: 69120 VAULX EN VELIN 
State:  
Zip Code:  
Telephone:  

Description of Business

Primary SIC Code: 3845
(As filed with the SEC)  

We develop and market the Ablatherm and Focal One devices, advanced choices for HIFU treatment of localized prostate cancer. HIFU treatment is shown to be a minimally invasive and effective treatment option for localized prostate cancer with a low occurrence of side effects. Ablatherm is generally recommended for patients with localized prostate cancer (stages T1-T2) who are not candidates for surgery or who prefer an alternative option. Focal One is a robot assisted HIFU device dedicated to the focal treatment of prostate cancer. Both HIFU devices are also used for patients who failed a radiotherapy treatment. In addition, we are developing a HIFU platform for the treatment of various types of tumors including rectal endometriosis, liver and pancreatic cancer, but also breast and gynecological tumors. We also produce and commercialize medical equipment for treatment of urinary tract stones using ESWL and distribute other types of urology devices in certain countries.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
12/20160.13NA25.23
06/20160.17NA19.47
12/2015-0.07NAN/E
12/2013-0.24NAN/E
09/2013-0.36NAN/E
06/2013-0.41NAN/E
03/2013-0.60NAN/E
12/2012-0.55NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.01Total Liab/Total Assets0.46
Net Inc/Total Assets-0.01Total Liab/Inv Cap0.79
Net Inc/Inv Cap-0.02Total Liab/Comm Equity0.32
Pretax Inc/Net Sales-0.01Interest Coverage RatioNA
Net Inc/Net Sales-0.02Curr Debt/Equity0.13
Cash Flow/Net Sales-0.09LTD/Equity0.05
SG&A/NetSales0.36Total Debt/Equity0.19
Asset Utilization   Liquidity  
Net Receivables Turnover3.38Quick Ratio2.04
Inventory Turnover3.04Current Ratio2.45
Inventory Day Sales0.01Net Rec/Curr Assets0.31
Net Sales/Work Cap1.52Inv/Curr Assets0.17
Net Sales/PP&E9.71  

Income Statement (Millions)

  12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Revenues(Net Sales) 42.92 37.56 35.04 32.41
Cost of Goods Sold 25.14 20.25 20.06 18.86
Selling & Admin Exps 15.56 12.82 11.52 12.11
Operating Income -2.43 0.41 0.53 -2.10
Interest Exp NA NA NA NA
Pretax Income -0.35 4.69 -0.99 -0.48
Other Income -1.09 0.11 0.76 -0.52
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -0.82 4.05 -1.81 -0.62

Balance Sheet (Millions)

Assets 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Cash & Short Term Investments 24.02 23.19 15.84 14.69
Receivables - Total 14.82 10.58 12.83 9.90
Inventories - Total 8.09 8.47 6.68 7.15
Total Current Assets 47.52 42.72 35.89 32.21
Net Property, Plant & Equipment 4.42 2.92 2.31 2.57
Total Assets 56.31 49.14 41.91 38.91
Liabilities        
Accounts Payable 11.58 11.00 12.21 10.40
Debt in Current Liabilities 4.03 2.18 3.54 2.98
Total Current Liabilities 19.37 15.83 17.68 14.71
Long-Term Debt 1.64 0.74 0.96 0.84
Total Liabilities 26.10 23.35 26.24 20.59
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 4.59 3.99 3.64 3.97
Retained Earnings -47.56 -41.06 -46.46 -49.74
Treasury Stock -1.37 -1.21 -1.24 -1.42
Total Stockholders' Equity 30.21 25.79 15.68 18.32
Total Liabilities and Stockholders' Equity 56.31 49.14 41.91 38.91

Cash Flow Summary (Millions)

Categories 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Cash Provided by Operating Activities -3.67 1.28 1.32 -1.23
Net Cash Provided by Investing Activities -2.44 -0.41 -0.59 -1.25
Net Cash Provided by Financing Activities 3.45 8.02 2.29 7.31

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/201333.18-6.92-0.24
12/201432.41-0.62--
12/201535.04-1.81-0.07
12/201637.564.050.13
12/201742.92-0.82--
Growth Rates6.65----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/18242,8049.67




Report Date : 7/9/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.